These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24254882)

  • 1. Simultaneous determination of the novel thiosemicarbazone anti-cancer agent, Bp4eT, and its main phase I metabolites in plasma: application to a pilot pharmacokinetic study in rats.
    Stariat J; Suprunová V; Roh J; Šesták V; Eisner T; Filipský T; Mladěnka P; Nobilis M; Šimůnek T; Klimeš J; Kalinowski DS; Richardson DR; Kovaříková P
    Biomed Chromatogr; 2014 May; 28(5):621-9. PubMed ID: 24254882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC-MS/MS identification of the principal in vitro and in vivo phase I metabolites of the novel thiosemicarbazone anti-cancer drug, Bp4eT.
    Stariat J; Sesták V; Vávrová K; Nobilis M; Kollárová Z; Klimeš J; Kalinowski DS; Richardson DR; Kovaříková P
    Anal Bioanal Chem; 2012 Apr; 403(1):309-21. PubMed ID: 22349326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an LC-MS/MS method for analysis of interconvertible Z/E isomers of the novel anticancer agent, Bp4eT.
    Stariat J; Kovaříková P; Klimeš J; Kalinowski DS; Richardson DR
    Anal Bioanal Chem; 2010 May; 397(1):161-171. PubMed ID: 20127082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of in vitro metabolites of the novel anti-tumor thiosemicarbazone, DpC, using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry.
    Stariat J; Kovaříková P; Kučera R; Klimeš J; Kalinowski DS; Richardson DR; Ketola RA
    Anal Bioanal Chem; 2013 Feb; 405(5):1651-61. PubMed ID: 23180090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats.
    Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.
    Potůčková E; Roh J; Macháček M; Sahni S; Stariat J; Šesták V; Jansová H; Hašková P; Jirkovská A; Vávrová K; Kovaříková P; Kalinowski DS; Richardson DR; Šimůnek T
    PLoS One; 2015; 10(10):e0139929. PubMed ID: 26460540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of larotaxel and its metabolites in rat plasma by liquid chromatography-tandem mass spectrometry: application for a pharmacokinetic study.
    Liu Z; Zhang L; Ju P; Hou P; Zhang Y; Tang X; Bi K; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():132-8. PubMed ID: 24413022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents.
    Stariat J; Kovaríková P; Klimes J; Lovejoy DB; Kalinowski DS; Richardson DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(3):316-22. PubMed ID: 19097949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel SPME fibers based on a plastic support for determination of plasma protein binding of thiosemicarbazone metal chelators: a case example of DpC, an anti-cancer drug that entered clinical trials.
    Reimerová P; Stariat J; Bavlovič Piskáčková H; Jansová H; Roh J; Kalinowski DS; Macháček M; Šimůnek T; Richardson DR; Štěrbová-Kovaříková P
    Anal Bioanal Chem; 2019 Apr; 411(11):2383-2394. PubMed ID: 30820631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of dipfluzine and its three metabolites in rat plasma using liquid chromatography-mass spectrometry.
    Guo W; Shi X; Wang W; Xiong C; Li J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():151-5. PubMed ID: 24424300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents.
    Sestak V; Stariat J; Cermanova J; Potuckova E; Chladek J; Roh J; Bures J; Jansova H; Prusa P; Sterba M; Micuda S; Simunek T; Kalinowski DS; Richardson DR; Kovarikova P
    Oncotarget; 2015 Dec; 6(40):42411-28. PubMed ID: 26623727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of cefadroxil in rat plasma and urine using LC-MS/MS and its application to pharmacokinetic and urinary excretion studies.
    Jin HE; Kim IB; Kim YC; Cho KH; Maeng HJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():103-10. PubMed ID: 24412692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a rapid LC-MS/MS method for the determination of JCC76, a novel antitumor agent for breast cancer, in rat plasma and its application to a pharmacokinetics study.
    Cai X; Zhong B; Su B; Xu S; Guo B
    Biomed Chromatogr; 2012 Sep; 26(9):1118-24. PubMed ID: 22213194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
    Furlong MT; Agrawal S; Hawthorne D; Lago M; Unger S; Krueger L; Stouffer B
    J Pharm Biomed Anal; 2012 Jan; 58():130-5. PubMed ID: 21982905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of genkwanin in rat plasma by liquid chromatography-tandem mass spectrometry: application to a bioavailability study.
    Song Y; Zhang S; Liu H; Jin X
    J Pharm Biomed Anal; 2013 Oct; 84():129-34. PubMed ID: 23831487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of sibutramine and its active metabolites in human plasma by LC-MS/MS and its application to a pharmacokinetic study.
    Bae JW; Choi CI; Jang CG; Lee SY
    Biomed Chromatogr; 2011 Nov; 25(11):1181-8. PubMed ID: 21294141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
    Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
    Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of blonanserin and its metabolite in human plasma and urine by liquid chromatography-tandem mass spectrometry: application to a pharmacokinetic study.
    Wen YG; Ni XJ; Zhang M; Liu X; Shang DW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():46-52. PubMed ID: 22818206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous determination of three isomeric metabolites of tacrolimus (FK506) in human whole blood and plasma using high performance liquid chromatography-tandem mass spectrometry.
    Chen YL; Hirabayashi H; Akhtar S; Pelzer M; Kobayashi M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):330-41. PubMed ID: 16318929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of piperphentonamine and metabolites M1 and M6 in human plasma and urine by LC/MS/MS and its application in a pharmacokinetics study in Chinese healthy volunteers.
    Shi A; Hu X; Li K; Li J; Han L; Wan H; Li R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():87-93. PubMed ID: 23122405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.